Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2021 Filed May 28, 2021 23:04 UTC |
EDWARDS JEFFREY LDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036675 · doc4.xml · derivative · entry 2 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:04 UTC |
EDWARDS JEFFREY LDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036675 · doc4.xml · nonDerivative · entry 1 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,800 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:02 UTC |
Cravatt BenjaminDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036671 · doc4.xml · derivative · entry 2 Cravatt Benjamin · CIK 0001819573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:02 UTC |
Cravatt BenjaminDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036671 · doc4.xml · nonDerivative · entry 1 Cravatt Benjamin · CIK 0001819573 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,614 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:01 UTC |
Brennan AoifeDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036668 · doc4.xml · derivative · entry 2 Brennan Aoife · CIK 0001714563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:01 UTC |
Brennan AoifeDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036668 · doc4.xml · nonDerivative · entry 1 Brennan Aoife · CIK 0001714563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,614 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:00 UTC |
Blaug SuzanneDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $20.86 | $0.00 |
DisclosureSEC source: 0001209191-21-036666 · doc4.xml · derivative · entry 2 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-05-25 F2 · derivative.exercise_date: Options vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| May 26, 2021 Filed May 28, 2021 23:00 UTC |
Blaug SuzanneDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036666 · doc4.xml · nonDerivative · entry 1 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,048 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of May 26, 2022 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC |
KEARNS THOMAS F JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2021-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC |
KEARNS THOMAS F JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2021-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC |
KEARNS THOMAS F JRDirector
|
SaleCommon Stock | 18,000 | $35.02 | $630,360.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,164 F1 · price: The shares were sold at prices ranging from $34.71 to $35.395. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 11, 2021 Filed Mar 15, 2021 22:22 UTC |
KEARNS THOMAS F JRDirector
|
Exercise / conversionCommon Stock | 18,000 | $3.50 | $63,000.00 |
DisclosureSEC source: 0001209191-21-020548 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,164 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:38 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Tax withholdingCommon Stock | 5,221 | $33.37 | $174,224.77 |
DisclosureSEC source: 0001209191-21-019555 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,346 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:34 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 5,657 | $33.37 | $188,774.09 |
DisclosureSEC source: 0001209191-21-019551 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,187 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:32 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 5,679 | $33.37 | $189,508.23 |
DisclosureSEC source: 0001209191-21-019549 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,597 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:28 UTC |
Wettig ThaneChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 32,100 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015013 · doc4.xml · derivative · entry 2 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,100 Underlying: Common Stock · 32,100 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:28 UTC |
Wettig ThaneChief Commercial Officer
|
GrantCommon Stock | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015013 · doc4.xml · nonDerivative · entry 1 Wettig Thane · CIK 0001815638 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,150 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:25 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
GrantStock Option (Right to Buy) · Derivative | 39,900 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015010 · doc4.xml · derivative · entry 2 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,900 Underlying: Common Stock · 39,900 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:25 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
GrantCommon Stock | 20,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015010 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,567 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:23 UTC |
Cotroneo PatSVP, Finance and CFO
|
GrantStock Option (Right to Buy) · Derivative | 41,700 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015009 · doc4.xml · derivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 Underlying: Common Stock · 41,700 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:23 UTC |
Cotroneo PatSVP, Finance and CFO
|
GrantCommon Stock | 21,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015009 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,844 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:21 UTC |
Chung ChristineSVP, China Operations
|
GrantStock Option (Right to Buy) · Derivative | 41,700 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015006 · doc4.xml · derivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,700 Underlying: Common Stock · 41,700 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:21 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 21,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015006 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,276 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:19 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 164,000 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001209191-21-015005 · doc4.xml · derivative · entry 3 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,000 Underlying: Common Stock · 164,000 shares Expires 2031-02-24 F2 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 00:19 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
GrantCommon Stock | 82,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-015005 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,273 F1 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:10 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $28.65 | $0.00 |
DisclosureSEC source: 0001209191-21-012546 · doc4.xml · derivative · entry 4 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2027-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:10 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 844 | $52.93 | $44,672.92 |
DisclosureSEC source: 0001209191-21-012546 · doc4.xml · nonDerivative · entry 3 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,100 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $52.76 to $53.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:10 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 5,156 | $52.31 | $269,710.36 |
DisclosureSEC source: 0001209191-21-012546 · doc4.xml · nonDerivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,944 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $51.76 to $52.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 17, 2021 Filed Feb 20, 2021 00:10 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 6,000 | $28.65 | $171,900.00 |
DisclosureSEC source: 0001209191-21-012546 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 00:24 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $19.05 | $0.00 |
DisclosureSEC source: 0001209191-21-004751 · doc4.xml · derivative · entry 3 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2026-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 00:24 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 6,000 | $43.38 | $260,280.00 |
DisclosureSEC source: 0001209191-21-004751 · doc4.xml · nonDerivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,100 F1 · kind: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| January 19, 2021 Filed Jan 22, 2021 00:24 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 6,000 | $19.05 | $114,300.00 |
DisclosureSEC source: 0001209191-21-004751 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2021 Filed Jan 16, 2021 01:02 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,999 | $0.00 Strike: $19.05 | $0.00 |
DisclosureSEC source: 0001209191-21-003917 · doc4.xml · derivative · entry 3 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 5,999 shares Expires 2026-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| January 14, 2021 Filed Jan 16, 2021 01:02 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 5,999 | $40.04 | $240,199.96 |
DisclosureSEC source: 0001209191-21-003917 · doc4.xml · nonDerivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,100 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $40.00 to $40.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 14, 2021 Filed Jan 16, 2021 01:02 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 5,999 | $19.05 | $114,280.95 |
DisclosureSEC source: 0001209191-21-003917 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2021 Filed Jan 9, 2021 00:40 UTC |
Conterno Enrique ADirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,411 | $38.31 | $207,295.41 |
DisclosureSEC source: 0001209191-21-002837 · doc4.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,273 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 684 shares acquired on November 13, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:08 UTC |
Schoeneck James ADirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $9.78 | $0.00 |
DisclosureSEC source: 0001209191-21-002361 · doc4.xml · derivative · entry 3 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2023-04-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully vested. Read SEC document |
| January 04, 2021 Filed Jan 7, 2021 00:08 UTC |
Schoeneck James ADirector
|
Exercise / conversionCommon Stock | 6,000 | $9.78 | $58,650.00 |
DisclosureSEC source: 0001209191-21-002361 · doc4.xml · nonDerivative · entry 1 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:07 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1 | $0.00 Strike: $19.05 | $0.00 |
DisclosureSEC source: 0001209191-20-065571 · doc4.xml · derivative · entry 6 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,999 Underlying: Common Stock · 1 shares Expires 2026-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:07 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $18.34 | $0.00 |
DisclosureSEC source: 0001209191-20-065571 · doc4.xml · derivative · entry 5 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2025-06-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:07 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 100 | $41.14 | $4,114.00 |
DisclosureSEC source: 0001209191-20-065571 · doc4.xml · nonDerivative · entry 4 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,100 F1 · kind: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:07 UTC |
Kurkijarvi KaleviDirector
|
SaleCommon Stock | 5,901 | $40.39 | $238,341.39 |
DisclosureSEC source: 0001209191-20-065571 · doc4.xml · nonDerivative · entry 3 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,200 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $40.00 to $40.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:07 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 1 | $19.05 | $19.05 |
DisclosureSEC source: 0001209191-20-065571 · doc4.xml · nonDerivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 23:07 UTC |
Kurkijarvi KaleviDirector
|
Exercise / conversionCommon Stock | 6,000 | $18.34 | $110,040.00 |
DisclosureSEC source: 0001209191-20-065571 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 00:06 UTC |
Yu K PeonyChief Medical Officer
|
SaleCommon Stock | 3,350 | $41.61 | $139,393.50 |
DisclosureSEC source: 0001209191-20-064228 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,292 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:04 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 3,068 | $43.60 | $133,764.80 |
DisclosureSEC source: 0001209191-20-064227 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,144 F1 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:34 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 3,292 | $41.99 | $138,231.08 |
DisclosureSEC source: 0001209191-20-062620 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,642 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:33 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Tax withholdingCommon Stock | 2,728 | $41.99 | $114,548.72 |
DisclosureSEC source: 0001209191-20-062619 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,767 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:30 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 3,014 | $41.99 | $126,557.86 |
DisclosureSEC source: 0001209191-20-062617 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,212 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 00:27 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 3,039 | $41.99 | $127,607.61 |
DisclosureSEC source: 0001209191-20-062615 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,576 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.